NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
01/24/2025
Back to search
Official data from USPTO
OHCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
01/24/2025
Trademark type
Combined
Nice classes
5
Filing date
03/08/2017
Registration date
05/15/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/24/2025
Last transaction
01/24/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/03/2017
First use in commerce
11/03/2017
Drawing code
3
Owner type
03
Owner location
ANYANG-SI, GYEONGGI-DO, KR
Examiner
SOBRAL, CHRISTINA
Current location
Historical data usage
Mark description
The mark consists of the stylized word "OHCARE" where the letters "OH" appear in red and the letters "CARE" appear in black, below the letters "OHC" is a red curved line and above the letter "h" is a red apostrophe.
Holders and representatives
Holders
OSANG HEALTHCARE CO., LTD.
INFOPIA CO., LTD.
Representatives
John Alumit ALUMIT IP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposesdiagnostic preparations for measuring blood sugardiagnostic preparations for measuring glycated hemoglobindiagnostic preparations for measuring cholesteroldiagnostic preparations for diagnosing liver diseasediagnostic preparations for diagnosing heart diseasediagnostic preparations for diagnosing cancer; Medical diagnostic test strips for use in the field of diabetes for measuring glycated hemoglobin and blood sugar; Medical diagnostic test strips for use in the field of hypercholesterolemia for measuring cholesterol levels; Medical diagnostic test strips for use in the field of liver disease; Medical diagnostic test strips for use in the field of cancer
Publications
History of USPTO decisions and trademark events.
31 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
01/24/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/23/2025
ES8R
TEAS SECTION 8 RECEIVED
04/26/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/15/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/10/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/09/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/05/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/05/2018
IUAF
USE AMENDMENT FILED
03/19/2018
EISU
TEAS STATEMENT OF USE RECEIVED
03/19/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/13/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/19/2017
PUBO
PUBLISHED FOR OPPOSITION
12/19/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/29/2017
ALIE
ASSIGNED TO LIE
11/15/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/02/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/02/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/28/2017
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
06/01/2017
GPRA
PRIORITY ACTION E-MAILED
06/01/2017
CPRA
PRIORITY ACTION WRITTEN
06/01/2017
DOCK
ASSIGNED TO EXAMINER
06/01/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/14/2017
NWAP
NEW APPLICATION ENTERED
03/11/2017
Continuous trademark protection
Get notified about every new filing that threatens OHCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.